$JANX https://t.co/j7somkrqw2
$JANX https://t.co/j7somkrqw2
$JANX: hold my beer!
$JANX ended -53%, $CTMX -11%. Here's yesterday's take from @ByMadeleineA at @ApexOnco https://t.co/5cQ4Xw32YM
@STL_Biotech That CRS prophylaxis tidbit might be the most deranged aspect of today's $JANX collapse. Wild!
A year ago we were warning you that $JANX was cherrypicking data. It all seems to be unravelling today, stock -50%
Wait... I thought biotech stock prices only go up? $JANX
$JNJ just acquired Halda for $3.05bn. Earlier story from @BatirtzeAreitio -> https://t.co/7nxuN3Oykj $JANX $CTMX
So all good still for $CTMX varsetatug masetecan (CX-2051)? Additional ph1 data by Q1 2026 is in line with January disclosure. What "recent social media posts" are they referring to? $JANX
$JANX resurrects a TROP2 asset, and continues tinkering with CD28. Meanwhile, JANX007 & JANX008 data are a waiting game. Via @ApexOnco -> https://t.co/kqO2x7AYOv $CTMX
So about $JANX introducing a TROP2 project to the pipeline... here's what it said in its S-1 in 2021 https://t.co/XtRXHCT1SC